We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$6.19B
AUM Growth
+$180M
Cap. Flow
-$115M
Cap. Flow %
-1.85%
Top 10 Hldgs %
21.67%
Holding
241
New
11
Increased
68
Reduced
137
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$16.9M
2
CLF icon
Cleveland-Cliffs
CLF
+$11.1M
3
CVS icon
CVS Health
CVS
+$8.97M
4
AA icon
Alcoa
AA
+$8.4M
5
IFF icon
International Flavors & Fragrances
IFF
+$7.96M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Technology 16.56%
3 Healthcare 15.52%
4 Industrials 11.68%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYT icon
126
New York Times
NYT
$10.2B
$3.19M 0.05%
81,005
-10,594
-12% -$403K
EA
127
DELISTED
Electronic Arts
EA
$2.57M 0.04%
19,796
-185,275
-90% -$23.5M
LUV icon
128
Southwest Airlines
LUV
$23B
$2.36M 0.04%
65,111
-4,721
-7% -$148K
FDX icon
129
FedEx
FDX
$75.4B
$2.2M 0.04%
8,865
-50
-0.6% -$11.4K
ADBE icon
130
Adobe
ADBE
$105B
$1.97M 0.03%
4,021
+177
+5% +$71.3K
ULTA icon
131
Ulta Beauty
ULTA
$24.3B
$1.83M 0.03%
3,893
-1,354
-26% -$663K
CL icon
132
Colgate-Palmolive
CL
$74.4B
$1.77M 0.03%
23,009
ABT icon
133
Abbott
ABT
$187B
$1.75M 0.03%
16,084
+101
+0.6% +$10.8K
APD icon
134
Air Products & Chemicals
APD
$67.6B
$1.73M 0.03%
5,788
-103
-2% -$29.3K
PFE icon
135
Pfizer
PFE
$153B
$1.71M 0.03%
46,579
-568
-1% -$22.1K
ABBV icon
136
AbbVie
ABBV
$435B
$1.67M 0.03%
12,417
+262
+2% +$38.4K
LLY icon
137
Eli Lilly
LLY
$1.06T
$1.6M 0.03%
3,409
-2
-0.1% -$839
WMT icon
138
Walmart Inc
WMT
$890B
$1.52M 0.02%
29,025
-1,011
-3% -$51K
INTC icon
139
Intel
INTC
$513B
$1.48M 0.02%
44,399
-6,042
-12% -$190K
CLB icon
140
Core Laboratories
CLB
$521M
$1.36M 0.02%
58,679
-25,453
-30% -$576K
ADP icon
141
Automatic Data Processing
ADP
$108B
$1.35M 0.02%
6,128
-440
-7% -$94.9K
LAMR icon
142
Lamar Advertising Co
LAMR
$16.3B
$1.33M 0.02%
13,429
-100
-0.7% -$9.7K
CAT icon
143
Caterpillar
CAT
$387B
$1.32M 0.02%
5,383
-172
-3% -$38.3K
ZTS icon
144
Zoetis
ZTS
$30B
$1.29M 0.02%
7,463
+960
+15% +$166K
SBUX icon
145
Starbucks
SBUX
$120B
$1.26M 0.02%
12,750
-58
-0.5% -$6.02K
VRSK icon
146
Verisk Analytics
VRSK
$25B
$1.24M 0.02%
5,499
-622
-10% -$131K
SSNC icon
147
SS&C Technologies
SSNC
$18.6B
$1.12M 0.02%
18,430
-9,612
-34% -$547K
GIS icon
148
General Mills
GIS
$19.7B
$1.1M 0.02%
14,389
-2,599
-15% -$222K
MRSH
149
Marsh
MRSH
$91.5B
$1.03M 0.02%
5,495
-25
-0.5% -$4.44K
VZ icon
150
Verizon
VZ
$196B
$1.03M 0.02%
27,612
-3,855
-12% -$143K

Similar funds

Douglas Lane & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Douglas Lane & Associates held 241 positions worth $6.19B, up 3% from $6.01B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q2 2023 filing shows 11 new, 68 increased, 137 reduced and 2 closed positions. Its largest new stake was Wheaton Precious Metals: 108,375 shares worth $4.68M. The largest sale was Maxar Technologies Inc. Common Stock, an estimated $82.8M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q2 2023 buy was Wheaton Precious Metals: 108,375 shares worth $4.68M.
  • Douglas Lane & Associates added most to RXO in Q2 2023, an estimated $16.9M increase.
  • Douglas Lane & Associates's biggest Q2 2023 reduction was Electronic Arts, cutting an estimated $23.5M.
  • Douglas Lane & Associates fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $82.8M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $6.19B portfolio in Q2 2023.
  • Douglas Lane & Associates opened 11 new positions and closed 2 in Q2 2023.
  • Douglas Lane & Associates's portfolio value rose 3% quarter-over-quarter to $6.19B.

Based on Douglas Lane & Associates's 13F filing for Q2 2023, filed 19 Jul 2023.